You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Meda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Meda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-12-02
Court	District Court, D. Delaware	Date Terminated	2017-05-17
Cause	28:2201 Declaratory Judgment	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	CIPLA LTD.; MEDA PHARMACEUTICALS INC.
Patents	8,163,723; 8,168,620; 9,259,428
Attorneys	Nicole W. Stafford; Tung-On Kong
Firms	Richards, Layton & Finger, PA; Selena E. Molina
Link to Docket	External link to docket

Small Molecule Drugs cited in Meda Pharmaceuticals Inc. v. Apotex Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Biologic Drugs cited in Meda Pharmaceuticals Inc. v. Apotex Inc.

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Meda Pharmaceuticals Inc. v. Apotex Inc. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-04-07	102		Initial Invalidity Contentions for U.S. Patent No. 9,259,428 Pursuant to the Courts Default Standard … 2014 17 May 2017 1:14-cv-01453 830 Patent None District Court, D. Delaware	External link to document
2016-05-12	114		alleging infringement of U.S. Patent Nos. 8,163,723 (the "' 723 patent"), 8,168,620 (the "…quot;'620 patent"), and 9,259,428 (the '"428 patent"). The patents are directed…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification … of the ' 723 patent and claims 16, 17, and 24 of the of the ' 620 patent. 3	External link to document
2016-12-11	148		Prejudice of all Claims Concerning U.S. Patent No. 8,163,723 by Cipla Ltd., Meda Pharmaceuticals Inc.… 2014 17 May 2017 1:14-cv-01453 830 Patent None District Court, D. Delaware	External link to document
2017-06-16	175		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,723; 8,168,620. (etg) (… 2014 17 May 2017 1:14-cv-01453 830 Patent None District Court, D. Delaware	External link to document
2015-07-13	30		Initial Infringement Contentions for U.S. Patent Nos. 8,163,723 and 8,168,620 filed by Cipla Ltd., Meda … 2014 17 May 2017 1:14-cv-01453 830 Patent None District Court, D. Delaware	External link to document
2014-12-01	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,723; 8,168,620;. (els) … 2014 17 May 2017 1:14-cv-01453 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.